MPN Genetics Announces Research Grants with focus on CRISPR

Funding option is available for researchers developing genome editing therapies for myeloproliferative diseases. A patient advocacy group called MPN (Myeloproliferative Neoplasms) Genetics and the Leukemia & Lymphoma Society announced "The 2015 MPN Challenge" grant program, one priority area being genome editing in MPN diseases. Deadline is April 1st. Check it out here: http://www.mpnresearchfoundation.org/2015-Request-for-Research-Proposals